203 related articles for article (PubMed ID: 36169065)
1. The sensitivity and specificity of methylene blue dye as a single agent in sentinel lymph node biopsy for early breast cancer.
Aimir M; Nasser A; Rokayah J; Hardin M; Sohail M
Med J Malaysia; 2022 Sep; 77(5):552-557. PubMed ID: 36169065
[TBL] [Abstract][Full Text] [Related]
2. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria.
Okoye CL; Ezeome ER
Niger J Clin Pract; 2022 Nov; 25(11):1805-1811. PubMed ID: 36412286
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Methylene Blue Test as Single Technique for Sentinel Lymph Node Biopsy in Early Stages Breast Cancer.
Hermansyah D; Rahayu Y; Azrah A; Pricilia G; Paramita D; Siregar ES; Sufida S; Simarmata A
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2765-2769. PubMed ID: 34582644
[TBL] [Abstract][Full Text] [Related]
4. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
6. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.
Brahma B; Putri RI; Karsono R; Andinata B; Gautama W; Sari L; Haryono SJ
World J Surg Oncol; 2017 Feb; 15(1):41. PubMed ID: 28173818
[TBL] [Abstract][Full Text] [Related]
8. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
[TBL] [Abstract][Full Text] [Related]
9. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases.
Moghimi M; Ghoddosi I; Rahimabadi AE; Sheikhvatan M
Scand J Surg; 2009; 98(1):30-3. PubMed ID: 19447739
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
Schwartz GF
Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
[TBL] [Abstract][Full Text] [Related]
13. The use of blue dye alone for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initially node-positive breast cancer.
Cavalcante FP; Zerwes FP; Souza ABA; Ziegelmann PK; Alcantara R; Cardoso A; Mattar A; Millen EC; Frasson AL
Eur J Surg Oncol; 2024 Mar; 50(3):107967. PubMed ID: 38262300
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.
East JM; Valentine CS; Kanchev E; Blake GO
BMC Surg; 2009 Jan; 9():2. PubMed ID: 19173714
[TBL] [Abstract][Full Text] [Related]
15. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
16. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
Kavallaris A; Camara O; Runnebaum IB
J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
[TBL] [Abstract][Full Text] [Related]
17. Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings.
Chavda J; Mishra A; Silodia A; Yadav SK; Sharma DB; Sharma D; Khandare M
Breast Cancer Res Treat; 2022 May; 193(1):105-110. PubMed ID: 35246773
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
